Format: online.
Dates: October 16th and 17th, 2020
-
Thursday, October 15th:
16:00-17:00 Executive Meeting (Closed meeting)
17:30-19:30 GEIS General Assembly (members only)
-
Friday, October, 16th:
15:20-15:30 Welcome & Introduction
Cleofé Romagosa, Claudia Valverde
15:30-16:30 SESSION 1: FOCUSING ON PATHOLOGY AND MOLECULAR BIOLOGY
Rosa Álvarez, Miquel Tarón
15:30-15:45 Technological potentials and challenges of liquid biopsy in sarcoma
Leonardo A. Meza Zepeda, Oslo University Hospital, Oslo, Norway
15:45-16:00 What’s new in WHO 2020?
Khin Thway, The Royal Marsden Hospital, London, United Kingdom
16:00-16:15 Any news in Nerve Seath Tumors?
Cleofé Romagosa, Vall d'Hebron Institute of Oncology Barcelona
16:15-16:30 Discussion
16:30-16:35 Break
16:35-17:50 SESSION 2: CHALLENGING ISSUES
Raquel Correa, Nadia Hindi
16:35-16:50 Chordoma and chondrosarcoma What has Radiotherapy to offer and at what price?
Carme Ares, Centro de Protonterapia Quirónsalud Madrid
16:50-17:05 TARPSWG achievings and future projects
Marco Fiore, Istituto Nazionale dei Tumori, Milan, Italy
17:05-17:20 When is isolated limb perfussion worth the trouble?
Alessandro Gronchi, Istituto Nazionale dei Tumori, Milan, Italy
17:20-17:35 How to deal with non ETS round cell sarcomas
William Tap, Memorial Sloan Kettering Cancer Center, New York (NY), USA
17:35-17:50 Discussion
17:50-17:55 Break
17:55-18:40 SESSION 3; SARCOMA SUBTYPE HIGHLIGHTED NTRK SARCOMA
Javier Martín Broto, Silvia Bagué
17:55-18:10 Pathologic insights Are we able to recognise translocated sarcomas?
Enrique De Álava, Virgen del Rocío Hospital, Seville
18:10-18:25 Treatment opportunities
Shreyas Patel, MD Anderson, Houston (TX), USA
18:25-18:40 Discussion
18:40-18:45 Break
18:45-20:00 SESSION 4: LET’S IMPROVE: ADVANCES IN IMMUNOTHERAPY
Soledad Gallego, Fina Cruz
18:45-19:00 Immune phenotypes in sarcoma Is it possible to strengthen immunogenicity
José Antonio López Martín, 12 Octubre Hospital, Madrid
19:00-19:15 TILs CARs and Modified TCR
Alena Gros, Vall d'Hebron University Hospital, Barcelona
19:15-19:30 Passive immunotherapeutics (monoclonal antibodies)
Robert Maki, Penn Medicine, Philadelphia (PA), USA
19:30-19:45 What’s the additional value of PET CT in the Response assesment to Immunotherapy
Mª José García, Clínica Universitaria de Navarra, Pamplona
19:45-20:00 Discussion
20:00-20:05 Farewell
Claudia Valverde
-
Saturday, October, 17th:
09:00-10:30 SIMPOSIO PARA PACIENTES
César Serrano, Javier Lavernia, Javier Martínez Trufero, Ana Sebio
09:00-09:05 Bienvenida
Dr. César Serrano García
09:05-09:30 Ser paciente en tiempos de COVID-19
Dr. Javier Martínez Trufero
09:30-10:00 Aspectos psicológicos asociados a tener un cáncer raro
Sara García Serrano y Dra. Ana Sebio García
10:00-10:30 Propuesta a debate para la realización de una encuesta nacional para pacientes y asociaciones de pacientes con sarcoma
Dr. Javier Lavernia Giner y Representantes de asociaciones de pacientes
-
-
Language:
Lectures will be delivered in English or Spanish. Simultaneous translation will be available on October, 16th.
-
Registrations:
Registration fees:
- Up to September, 15th: 400€ Spanish VAT included
- After September, 15th: 550€ Spanish VAT included
.
Method of Payment:
By bank transfer:
Bank account holder: Grupo Español de Investigación en Sarcomas
IBAN: CAIXABANK ES22 2100 0827 10 0200642611
-
Symposium Secretariat:
Grupo Español de Investigación en Sarcomas (GEIS)
E-mail: eventos(arroba)grupogeis.org
Tel.: (+34) 912 866 807
Sponsors
Other Sponsors
